BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND TOP2A, TOP2, TP2A AND Diagnosis
13 results:

  • 1. [Expression of ProEXC and PRMT5 in cervical adenocarcinoma and their clinical significance].
    Cui HX; Lou XL; Xia W; Zhang YS; Cheng XY; Deng LF
    Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(48):3967-3971. PubMed ID: 38129175
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Bioinformatics and cheminformatics approaches to identify pathways, molecular mechanisms and drug substances related to genetic basis of cervical cancer.
    Andalib KMS; Rahman MH; Habib A
    J Biomol Struct Dyn; 2023; 41(23):14232-14247. PubMed ID: 36852684
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for cervical cancer.
    Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Expression analysis of p16 and top2a protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania.
    Zuberi Z; Mremi A; Chilongola JO; Semango G; Sauli E
    PLoS One; 2021; 16(10):e0259096. PubMed ID: 34705880
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. top2a/MCM2, p16
    Del Moral-Hernández O; Hernández-Sotelo D; Alarcón-Romero LDC; Mendoza-Catalán MA; Flores-Alfaro E; Castro-Coronel Y; Ortiz-Ortiz J; Leyva-Vázquez MA; Ortuño-Pineda C; Castro-Mora W; Illades-Aguiar B
    BMC Cancer; 2021 Jan; 21(1):39. PubMed ID: 33413211
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for cervical cancer: A Bioinformatics Analysis.
    Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
    Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.
    Yang HJ; Xue JM; Li J; Wan LH; Zhu YX
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1200. PubMed ID: 32181600
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.
    Wu DM; Shi J; Liu T; Deng SH; Han R; Xu Y
    Cancer Biomark; 2018 Feb; 21(2):355-365. PubMed ID: 29103025
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ProEx C as Diagnostic Marker for Detection of Urothelial Carcinoma in Urinary Samples: A Review.
    Botti G; Malzone MG; La Mantia E; Montanari M; Vanacore D; Rossetti S; Quagliariello V; Cavaliere C; Di Franco R; Castaldo L; Ametrano G; Cappuccio F; Romano FJ; Piscitelli R; Pepe MF; D'Aniello C; Facchini G
    Int J Med Sci; 2017; 14(6):554-559. PubMed ID: 28638271
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer.
    Tornesello ML; Buonaguro L; Giorgi-Rossi P; Buonaguro FM
    Biomed Res Int; 2013; 2013():519619. PubMed ID: 24383054
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A cocktail of MCM2 and top2a, p16INK4a and Ki-67 as biomarkers for the improved diagnosis of cervical intraepithelial lesion.
    Yang QC; Zhu Y; Liou HB; Zhang XJ; Shen Y; Ji XH
    Pol J Pathol; 2013 Apr; 64(1):21-7. PubMed ID: 23625596
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics.
    Aximu D; Azad A; Ni R; Colgan T; Nanji S
    Int J Gynecol Pathol; 2009 Mar; 28(2):114-9. PubMed ID: 19188825
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.
    Santin AD; Zhan F; Bignotti E; Siegel ER; Cané S; Bellone S; Palmieri M; Anfossi S; Thomas M; Burnett A; Kay HH; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Virology; 2005 Jan; 331(2):269-91. PubMed ID: 15629771
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.